Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
5,421,812
-
Share change
-
-660,553
-
Total reported value
-
$2,702,978
-
Put/Call ratio
-
44%
-
Price per share
-
$0.50
-
Number of holders
-
24
-
Value change
-
-$510,765
-
Number of buys
-
5
-
Number of sells
-
18
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q4 2019
As of 31 Dec 2019,
INTEC PHARMA LTD JERUSALEM - SHS was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,421,812 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, ADAGE CAPITAL PARTNERS GP, L.L.C., AdvisorShares Investments LLC, Harel Insurance Investments & Financial Services Ltd., ETF MANAGERS GROUP, LLC, Phoenix Holdings Ltd., Virtu Financial LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.